| Reduced spinal bone density in young women with amenorrhoea. | |
| | |
MedLine Citation:
|
PMID: 1834488 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
To assess the influence of diminished oestrogen production on bone density, we studied 23 amenorrhoeic women and 20 controls (age range 16-29 years) divided into four groups: group 1: 6 patients with idopathic hypogonadotrophic hypogonadism with primary amenorrhoea (IHH); group 2: 5 patients with delayed puberty owing to thalassaemia major (TM); group 3: 12 patients with secondary hypothalamic amenorrhoea (HA); group 4: 20 women with normal menses (controls). Secondary sexual characteristics had developed in all except the women with TM. Groups 1 and 2 had never menstruated and group 3 had been amenorrhoeic for 6 months to 3 years. The control group was studied during the follicular phase of the cycle. None of the patients were taking oestrogens at the time of observation. Plasma concentrations were determined for 17 beta-oestradiol (E2), deidroepiandrosterone sulphate (DHEA-S), cortisol (F), prolactin (PRL), thyroid hormones (T3 and T4), and gonadotrophins (LH and FSH). Spinal bone mineral density (BMD g/cm2) was assessed by dual photon absorbiometry. BMD (mean +/- 1SD) was reduced in the patients (group 2: 0.920 +/- 0.95; group 1: 0.980 +/- 0.94; and group 3: 1.037 +/- 0.75) as compared with the controls (1.290 +/- 0.95) (P less than 0.01). In the three groups of patients, plasma E2 levels were lower than 50 pg/ml and were positively correlated with the BMD. As expected, plasma gonadotrophin levels were highly and significantly reduced (P less than 0.01) in the patients, compared with that of the controls. These results suggest that reduced spinal BMD in hypogonadic women may be related to the lack of oestrogenic influence on bone metabolism.(ABSTRACT TRUNCATED AT 250 WORDS) |
| | |
Authors:
|
G Fabbri; F Petraglia; A Segre; A Maietta-Latessa; M C Galassi; M Cellini; S Sardelli; F Massolo; A Genazzani; A R Genazzani |
Related Documents
:
|
16086108 - A histomorphometric study of cortical bone of the iliac crest in patients treated with ... 19240658 - The effect of alendronate sodium on carotid artery intima-media thickness and lipid pro... 2126198 - Five years with continuous combined oestrogen/progestogen therapy. effects on calcium m... 9071478 - Alendronate in the treatment of paget's disease of bone. 8856618 - Comparison of the antiinflammatory efficacy of chondroitin sulfate and diclofenac sodiu... 22883288 - Rituximab in severe seronegative juvenile myasthenia gravis: review of the literature. |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: European journal of obstetrics, gynecology, and reproductive biology Volume: 41 ISSN: 0301-2115 ISO Abbreviation: Eur. J. Obstet. Gynecol. Reprod. Biol. Publication Date: 1991 Sep |
Date Detail:
|
Created Date: 1991-12-20 Completed Date: 1991-12-20 Revised Date: 2004-11-17 |
Medline Journal Info:
|
Nlm Unique ID: 0375672 Medline TA: Eur J Obstet Gynecol Reprod Biol Country: NETHERLANDS |
Other Details:
|
Languages: eng Pagination: 117-22 Citation Subset: IM |
Affiliation:
|
Department of Obstetrics and Gynaecology, University of Modena, Italy. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adolescent Adult Amenorrhea / complications*, physiopathology Bone Density* Dehydroepiandrosterone / blood Estradiol / blood Female Humans Hydrocortisone / blood Luteinizing Hormone / blood Osteoporosis / complications*, physiopathology Prolactin / blood Spinal Diseases / complications*, physiopathology Thyroid Hormones / blood |
| Chemical | |
Reg. No./Substance:
|
0/Thyroid Hormones; 50-23-7/Hydrocortisone; 50-28-2/Estradiol; 53-43-0/Dehydroepiandrosterone; 9002-62-4/Prolactin; 9002-67-9/Luteinizing Hormone |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Hyperinsulinaemia as predictor of atherosclerotic vascular disease: epidemiological evidence.
Next Document: Treatment of tubal pregnancy by local injection of prostaglandin: selection of patients and evaluati...